These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 31374104)
1. HCV and flaviviruses hijack cellular mechanisms for nuclear STAT2 degradation: Up-regulation of PDLIM2 suppresses the innate immune response. Joyce MA; Berry-Wynne KM; Dos Santos T; Addison WR; McFarlane N; Hobman T; Tyrrell DL PLoS Pathog; 2019 Aug; 15(8):e1007949. PubMed ID: 31374104 [TBL] [Abstract][Full Text] [Related]
2. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections. Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624 [TBL] [Abstract][Full Text] [Related]
3. PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB. Jodo A; Shibazaki A; Onuma A; Kaisho T; Tanaka T Front Immunol; 2020; 11():1559. PubMed ID: 32849529 [TBL] [Abstract][Full Text] [Related]
5. PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit. Tanaka T; Grusby MJ; Kaisho T Nat Immunol; 2007 Jun; 8(6):584-91. PubMed ID: 17468759 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha. Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377 [TBL] [Abstract][Full Text] [Related]
7. STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α. Yamauchi S; Takeuchi K; Chihara K; Honjoh C; Kato Y; Yoshiki H; Hotta H; Sada K Sci Rep; 2016 Dec; 6():38336. PubMed ID: 27929099 [TBL] [Abstract][Full Text] [Related]
8. PCBP2 enhances the antiviral activity of IFN-α against HCV by stabilizing the mRNA of STAT1 and STAT2. Xin Z; Han W; Zhao Z; Xia Q; Yin B; Yuan J; Peng X PLoS One; 2011; 6(10):e25419. PubMed ID: 22022391 [TBL] [Abstract][Full Text] [Related]
9. Neuralized E3 Ubiquitin Protein Ligase 3 Is an Inducible Antiviral Effector That Inhibits Hepatitis C Virus Assembly by Targeting Viral E1 Glycoprotein. Zhao Y; Cao X; Guo M; Wang X; Yu T; Ye L; Han L; Hei L; Tao W; Tong Y; Xu Y; Zhong J J Virol; 2018 Nov; 92(21):. PubMed ID: 30111563 [TBL] [Abstract][Full Text] [Related]
10. NS5-independent Ablation of STAT2 by Zika virus to antagonize interferon signalling. Shu J; Ma X; Zhang Y; Zou J; Yuan Z; Yi Z Emerg Microbes Infect; 2021 Dec; 10(1):1609-1625. PubMed ID: 34340648 [No Abstract] [Full Text] [Related]
11. STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1. Blaszczyk K; Olejnik A; Nowicka H; Ozgyin L; Chen YL; Chmielewski S; Kostyrko K; Wesoly J; Balint BL; Lee CK; Bluyssen HA Biochem J; 2015 Mar; 466(3):511-24. PubMed ID: 25564224 [TBL] [Abstract][Full Text] [Related]
12. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection. Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994 [TBL] [Abstract][Full Text] [Related]
13. PDLIM2 inhibits T helper 17 cell development and granulomatous inflammation through degradation of STAT3. Tanaka T; Yamamoto Y; Muromoto R; Ikeda O; Sekine Y; Grusby MJ; Kaisho T; Matsuda T Sci Signal; 2011 Dec; 4(202):ra85. PubMed ID: 22155789 [TBL] [Abstract][Full Text] [Related]
14. Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: relevance to hepatitis C. Joshi-Barve S; Amancherla K; Patil M; Bhatnagar A; Mathews S; Gobejishvili L; Cave M; McClain C; Barve S Free Radic Biol Med; 2009 Jul; 47(1):47-54. PubMed ID: 19345260 [TBL] [Abstract][Full Text] [Related]
16. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells. Plumlee CR; Lazaro CA; Fausto N; Polyak SJ Virol J; 2005 Dec; 2():89. PubMed ID: 16324217 [TBL] [Abstract][Full Text] [Related]
17. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon. Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma. Wurster KD; Hummel F; Richter J; Giefing M; Hartmann S; Hansmann ML; Kreher S; Köchert K; Krappmann D; Klapper W; Hummel M; Wenzel SS; Lenz G; Janz M; Dörken B; Siebert R; Mathas S Leukemia; 2017 Mar; 31(3):602-613. PubMed ID: 27538486 [TBL] [Abstract][Full Text] [Related]
19. Antagonism of type I interferon by flaviviruses. Miorin L; Maestre AM; Fernandez-Sesma A; García-Sastre A Biochem Biophys Res Commun; 2017 Oct; 492(4):587-596. PubMed ID: 28576494 [TBL] [Abstract][Full Text] [Related]
20. Zika virus NS5 protein inhibits type I interferon signaling via CRL3 E3 ubiquitin ligase-mediated degradation of STAT2. Ren W; Fu C; Zhang Y; Ju X; Jiang X; Song J; Gong M; Li Z; Fan W; Yao J; Ding Q Proc Natl Acad Sci U S A; 2024 Aug; 121(34):e2403235121. PubMed ID: 39145933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]